Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-17

Clinical Trial Update: Wearable Technology and Machine Learning for Early Detection and Risk Assessment of Unacceptable Toxicities in a Paediatric Oncology Cohort

View source ↗

Summary

A pediatric cancer trial uses wearable devices and machine learning to detect early signs of unacceptable toxicities and assess toxicity risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Murdoch Childrens Research Institute | Conditions: Cancer, Infection | Status: RECRUITING